Literature DB >> 16645637

Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy.

A Hamacher-Brady1, N R Brady, S E Logue, M R Sayen, M Jinno, L A Kirshenbaum, R A Gottlieb, A B Gustafsson.   

Abstract

Ischemia and reperfusion (I/R) injury is associated with extensive loss of cardiac myocytes. Bnip3 is a mitochondrial pro-apoptotic Bcl-2 protein which is expressed in the adult myocardium. To investigate if Bnip3 plays a role in I/R injury, we generated a TAT-fusion protein encoding the carboxyl terminal transmembrane deletion mutant of Bnip3 (TAT-Bnip3DeltaTM) which has been shown to act as a dominant negative to block Bnip3-induced cell death. Perfusion with TAT-Bnip3DeltaTM conferred protection against I/R injury, improved cardiac function, and protected mitochondrial integrity. Moreover, Bnip3 induced extensive fragmentation of the mitochondrial network and increased autophagy in HL-1 myocytes. 3D rendering of confocal images revealed fragmented mitochondria inside autophagosomes. Enhancement of autophagy by ATG5 protected against Bnip3-mediated cell death, whereas inhibition of autophagy by ATG5K130R enhanced cell death. These results suggest that Bnip3 contributes to I/R injury which triggers a protective stress response with upregulation of autophagy and removal of damaged mitochondria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16645637     DOI: 10.1038/sj.cdd.4401936

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  287 in total

1.  Autophagosome formation is required for cardioprotection by chloramphenicol.

Authors:  Zoltán Giricz; Zoltán V Varga; Gábor Koncsos; Csilla Terézia Nagy; Anikó Görbe; Robert M Mentzer; Roberta A Gottlieb; Péter Ferdinandy
Journal:  Life Sci       Date:  2017-08-01       Impact factor: 5.037

2.  Bnip3 impairs mitochondrial bioenergetics and stimulates mitochondrial turnover.

Authors:  S Rikka; M N Quinsay; R L Thomas; D A Kubli; X Zhang; A N Murphy; Å B Gustafsson
Journal:  Cell Death Differ       Date:  2010-11-19       Impact factor: 15.828

3.  New roles for mitochondria in cell death in the reperfused myocardium.

Authors:  Sang-Bing Ong; Asa B Gustafsson
Journal:  Cardiovasc Res       Date:  2011-11-22       Impact factor: 10.787

4.  BNip3 regulates mitochondrial function and lipid metabolism in the liver.

Authors:  Danielle Glick; Wenshuo Zhang; Michelle Beaton; Glenn Marsboom; Michaela Gruber; M Celeste Simon; John Hart; Gerald W Dorn; Matthew J Brady; Kay F Macleod
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

5.  Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy.

Authors:  Rita A Hanna; Melissa N Quinsay; Amabel M Orogo; Kayla Giang; Shivaji Rikka; Åsa B Gustafsson
Journal:  J Biol Chem       Date:  2012-04-13       Impact factor: 5.157

6.  The role of E2F-1 and downstream target genes in mediating ischemia/reperfusion injury in vivo.

Authors:  Ekaterini Angelis; Peng Zhao; Rui Zhang; Joshua I Goldhaber; W Robb Maclellan
Journal:  J Mol Cell Cardiol       Date:  2011-09-22       Impact factor: 5.000

Review 7.  Autophagy in ischemic heart disease.

Authors:  Asa B Gustafsson; Roberta A Gottlieb
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

8.  When apoptosis meets autophagy: deciding cell fate after trauma and sepsis.

Authors:  Ya-Ching Hsieh; Mohammad Athar; Irshad H Chaudry
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

Review 9.  Structure, function, and epigenetic regulation of BNIP3: a pathophysiological relevance.

Authors:  Nagarjuna Vasagiri; Vijay Kumar Kutala
Journal:  Mol Biol Rep       Date:  2014-08-06       Impact factor: 2.316

Review 10.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.